COMBINATORIAL MOLECULAR PHARMACOLOGICAL AND PRECLINICAL STUDIES OF AN EPIGENETIC ANTICANCER DRUG, 3-DEAZANEPLANOCIN A, IN RATS

COMBINATORIAL MOLECULAR PHARMACOLOGICAL AND PRECLINICAL STUDIES OF AN EPIGENETIC ANTICANCER DRUG, 3-DEAZANEPLANOCIN A, IN RATS

Ph.D

Saved in:

書目詳細資料
主要作者:	SUN FENG
其他作者:	PHARMACY
格式:	Theses and Dissertations
語言:	English
出版:	2011
主題:	3-deazaneplanocin A, epigenetics, molecular pharmacology, preclinical study, pharmacokinetics, liposomes
在線閱讀:	http://scholarbank.nus.edu.sg/handle/10635/22961
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!
機構:	National University of Singapore
語言:	English

相似書籍

Loading 3-deazaneplanocin A into pegylated unilamellar liposomes by forming transient phenylboronic acid-drug complex and its pharmacokinetic features in Sprague-Dawley rats
由: Sun, F., et al.
出版: (2014)

Quantification of 3-deazaneplanocin A, a novel epigenetic anticancer agent, in rat biosamples by hydrophilic interaction liquid chromatography-tandem mass spectrometric detection
由: Sun, F., et al.
出版: (2014)

PRECLINICAL INVESTIGATION OF 3-DEAZANEPLANOCIN A (DZNEP) ANALOG 1-3 AS A NEW EPIGENETIC ANTICANCER AGENT IN HUMAN ACUTE MYELOID LEUKEMIA (AML) AND METASTATIC BREAST CANCER
由: JIANG XIA
出版: (2014)

Pharmacokinetics of intravenously administered stealth liposomal doxorubicin modulated with verapamil in rats
由: Wang, J.-C., et al.
出版: (2011)

Lipid-based nanoparticulate systems for the delivery of anti-cancer drug cocktails: Implications on pharmacokinetics and drug toxicities
由: Chiu, G.N.C., et al.
出版: (2014)

Transcriptome-wide elucidation of liposomal formulations for anticancer drug delivery
由: Huang, Bu-Wei, et al.
出版: (2018)

Polygenic hazard scores in preclinical Alzheimer's disease
由: TAN, Chin Hong, et al.
出版: (2017)

Focus on formononetin: Anticancer potential and molecular targets
由: Ong, S.K.L., et al.
出版: (2022)

A cationic liposomal vincristine formulation with improved vincristine retention, extended circulation lifetime and increased anti-tumor activity
由: Webb, M.S., et al.
出版: (2014)

EPIGENETIC TARGETED DRUG DISCOVERY: INHIBITORS OF METHYLTRANSFERASE G9A AND DUAL INHIBITORS OF G9A and HDAC
由: UTTARA SOUMYANARAYANAN
出版: (2018)

Clinical pharmacology and pharmacogenetics of gemcitabine
由: Wong, A., et al.
出版: (2014)

HYPOXIA MEDIATES TUMOURIGENESIS VIA THE H3K9 EPIGENETIC REGULATORS G9A AND JMJD1A
由: HO CAIFENG JOLENE
出版: (2015)

Environmental origins of hypertension: Phylogeny, ontogeny and epigenetics
由: Leow M.K.-S.
出版: (2020)

Cell-based proteome profiling using an affinity-based probe (AfBP) derived from 3-deazaneplanocin A (DzNep)
由: Tam, E.K.W., et al.
出版: (2014)

Preclinical Large Animal In-Vivo Experiments for Surgically Implanted Atrioventricular Valve: Reappraisal and Systematic Review.
由: Sazzad, Faizus, et al.
出版: (2022)

Epigenetic regulation of inflammation in stroke
由: Yong-Quan, Gavin, et al.
出版: (2020)

A nanocapsular combinatorial sequential drug delivery system for antiangiogenesis and anticancer activities
由: Wang, Z., et al.
出版: (2014)

EPIGENETIC EFFECTS ON GENE REGULATION DURING CELL DIFFERENTIATION, DEVELOPMENT AND DISEASE
由: LIM YEN CHING
出版: (2015)

Optimization and therapeutic activity of liposome-conjugated monoclonal antibodies against the ErbB family of receptor tyrosine kinases: First step in the development of therapeutic antibody/liposomal anticancer drug combinations
由: Chiu, G.N.C., et al.
出版: (2014)

Epigenetic disturbances in obesity and diabetes : epidemiological and functional insights
由: Loh, Marie, et al.
出版: (2020)

The functional roles of poly(ethylene glycol)-lipid and lysolipid in the drug retention and release from lysolipid-containing thermosensitive liposomes in vitro and in vivo
由: Banno, B., et al.
出版: (2014)

Characteristics of epigenetic aging across gestational and perinatal tissues
由: Dieckmann, Linda, et al.
出版: (2022)

P53 GENOMIC STATUS REGULATES SENSITIVITY OF GASTRIC CANCER CELLS TO THE HISTONE METHYLATION INHIBITOR 3-DEAZANEPLANOCIN A (DZNEP)
由: CHENG LAI LING
出版: (2012)

EPIGENETIC REGULATION OF CYTOSOLIC PHOSPHOLIPASE A2
由: TAN SIEW HON CHARLENE
出版: (2015)

Pharmacologic modulation strategies to reduce dose requirements of anticancer therapy while preserving clinical efficacy
由: Zee, Y.-K., et al.
出版: (2014)

Dietary phytochemical PEITC restricts tumor development via modulation of epigenetic writers and erasers
由: Park, Jung Eun, et al.
出版: (2017)

Vitamin E TPGS as a molecular biomaterial for drug delivery
由: Zhang, Z., et al.
出版: (2014)

Vitamin E TPGS as a molecular biomaterial for drug delivery
由: Zhang, Z., et al.
出版: (2014)

Clinical Drug Development - Practical Issues in Clinical Pharmacology Studies
由: Wise, S.D.
出版: (2014)

Maternal Prenatal Anxiety and the Fetal Origins of Epigenetic Aging
由: McGill M.G., et al.
出版: (2022)

EPIGENETIC REGULATION OF CELL STATE TRANSITIONS IN TRIPLE NEGATIVE BREAST CANCER
由: TOH LI PING
出版: (2021)

Drug delivery by liponanocapsules : a new nanomedicine concept
由: Lan, Xin
出版: (2014)

Lipid-coated polymeric nanoparticles for cancer drug delivery
由: Krishnamurthy, Sangeetha, et al.
出版: (2015)

GENOMIC STUDIES OF EPIGENETIC DEREGULATION IN CANCER
由: ROBERTO TIRADO MAGALLANES
出版: (2021)

Quantification of α- And β-amyrin in rat plasma by gas chromatography-mass spectrometry: Application to preclinical pharmacokinetic study
由: Ching, J., et al.
出版: (2014)

Inheritance of acquired traits in insects and other animals and the epigenetic mechanisms that break the weismann barrier
由: Gowri, V., et al.
出版: (2022)

EPIGENETIC, TRANSCRIPTOMIC AND CYTOGENETIC MECHANISM OF INTERMITTENT FASTING
由: NG YONG QUAN GAVIN
出版: (2020)

Pharmacokinetics of Codeine in Mitragynine-pretreated Rats
由: Hawanee Saca
出版: (2024)

EMG analysis for pre-clinical trials of hand rehabilitation tasks
由: Ang, Kok Yong
出版: (2013)

Pharmacology of Gemcitabine in the Asian Population
由: WANG LINGZHI
出版: (2010)